Miramar Labs develops medical devices for aesthetic indications that treat primary axillary hyperhidrosis in adults.
Miramar Labs develops medical devices for aesthetic indications that treat primary axillary (underarm) hyperhidrosis in adults. The miraDry System cannot be used to treat hyperhidrosis elsewhere on the body, including the hands and feet. It was founded in 2006 and is based in Sunnyvale, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 8, 2016 | Series Unknown | — | 5 | — | — | Detail |
Jun 8, 2016 | IPO | $9M | — | — | — | Detail |
May 23, 2016 | Debt Financing | $4.32M | — | — | — | Detail |
Dec 24, 2015 | Debt Financing | $1.26M | — | — | — | Detail |
Oct 6, 2014 | Series D | $26M | 5 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
RusnanoMedInvest | — | Series Unknown |
Aisling Capital | — | Series Unknown |
Domain Associates | — | Series Unknown |
Montrose Capital Partners | — | Series Unknown |
Morgenthaler Ventures | — | Series Unknown |
Cross Creek | — | Series D |
RMI Partners | — | Series D |
Split Rock Partners | — | Series B |
The Weekly Review | — | Series B |